Evidence map›Paper›PMID 28293300›Full record

ArticleEpigenetics & chromatin2017

Silencing markers are retained on pericentric heterochromatin during murine primordial germ cell development.

Aristea Magaraki, Godfried van der Heijden, Esther Sleddens-Linkels, Leonidas Magarakis, Wiggert A van Cappellen, Antoine H F M Peters, Joost Gribnau, Willy M Baarends, Maureen Eijpe

Open access · goldAbstract read
In one paragraph

Article in Epigenetics & chromatin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The repair geneOncology reviews · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Aristea MagarakiDepartment of Developmental Biology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Godfried van der HeijdenDivision of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus MC, Rotterdam, The Netherlands.
Esther Sleddens-LinkelsDepartment of Developmental Biology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Leonidas MagarakisDivision of Reproductive Medicine, Department of Obstetrics and Gynecology, Central Hospital of Karlstad, Karlstad, Värmland Sweden.
Wiggert A van CappellenErasmus Optical Imaging Center, Erasmus MC, Rotterdam, The Netherlands.
Antoine H F M PetersFriedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Joost GribnauDepartment of Developmental Biology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Willy M Baarends *Department of Developmental Biology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-9179-850X
Maureen Eijpe *Department of Developmental Biology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLKarlstad Central Hospital · SEUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the nuclei of most mammalian cells, pericentric heterochromatin is characterized by DNA methylation, histone modifications such as H3K9me3 and H4K20me3, and specific binding proteins like heterochromatin-binding protein 1 isoforms (HP1 isoforms). Maintenance of this specialized chromatin structure is of great importance for genome integrity and for the controlled repression of the repetitive elements within the pericentric DNA sequence. Here we have studied histone modifications at pericentric heterochromatin during primordial germ cell (PGC) development using different fixation conditions and fluorescent immunohistochemical and immunocytochemical protocols.

resultsWe observed that pericentric heterochromatin marks, such as H3K9me3, H4K20me3, and HP1 isoforms, were retained on pericentric heterochromatin throughout PGC development. However, the observed immunostaining patterns varied, depending on the fixation method, explaining previous findings of a general loss of pericentric heterochromatic features in PGCs. Also, in contrast to the general clustering of multiple pericentric regions and associated centromeres in DAPI-dense regions in somatic cells, the pericentric regions of PGCs were more frequently organized as individual entities. We also observed a transient enrichment of the chromatin remodeler ATRX in pericentric regions in embryonic day 11.5 (E11.5) PGCs. At this stage, a similar and low level of major satellite repeat RNA transcription was detected in both PGCs and somatic cells.

conclusionsThese results indicate that in pericentric heterochromatin of mouse PGCs, only minor reductions in levels of some chromatin-associated proteins occur, in association with a transient increase in ATRX, between E11.5 and E13.5. These pericentric heterochromatin regions more frequently contain only a single centromere in PGCs compared to the surrounding soma, indicating a difference in overall organization, but there is no de-repression of major satellite transcription.

Indexed as

AnimalsCentromereChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneEmbryo, MammalianGene SilencingGerm CellsHeterochromatinHistonesImmunohistochemistryMiceMicroscopy, FluorescenceProtein IsoformsChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneHeterochromatinHistonesProtein IsoformsATRXCentromereH3K9me3H4K20me3Histone modificationsHP1ImmunochemistryMajor satellitesPericentric heterochromatinPrimordial germ cell

Identifiers

PMID28293300
PMCPMC5346203
OpenAlexW2593916438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.